1.Hauser SL, Oksenberg JR. The neurobiology of multiple
sclerosis: genes, inflammation, and neurodegeneration.
Neuron. 2006;52(1):61-76. doi:
10.1016/j.neuron.2006.09.011 pmid: 17015227
2. Liguori M, Marrosu MG, Pugliatti M, Giuliani F, De Robertis
F, Cocco E, et al. Age at onset in multiple sclerosis. Neurol Sci.
2000;21(4 Suppl 2):S825-9. doi: 10.1007/s100720070020
pmid: 11205357
3. Eskandarieh S, Heydarpour P, Elhami S-R, Sahraian MA.
Prevalence and incidence of multiple sclerosis in Tehran, Iran.
Iran J Pub Health. 2017;46(5):699.
4. Ghezzi A, Deplano V, Faroni J, Grasso MG, Liguori M,
Marrosu G, et al. Multiple sclerosis in childhood: clinical
features of 149 cases. Mult Scler. 1997;3(1):43-6. doi:
10.1177/135245859700300105 pmid: 9160345
5. International Multiple Sclerosis Genetics C, Wellcome Trust
Case Control C, Sawcer S, Hellenthal G, Pirinen M, Spencer
CC, et al. Genetic risk and a primary role for cell-mediated
immune mechanisms in multiple sclerosis. Nature.
2011;476(7359):214-9. doi: 10.1038/nature10251 pmid:
21833088
6. Stuve O, Oksenberg J. Multiple Sclerosis Overview. In: Pagon
RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean
LJH, editors. GeneReviews. Seattle: University of Washington;
1993.
7. Lundstrom W, Fewkes NM, Mackall CL. IL-7 in human health
and disease. Semin Immunol. 2012;24(3):218-24. doi:
10.1016/j.smim.2012.02.005 pmid: 22410365
8. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop
A, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic
and functional association with multiple sclerosis. Nat Genet.
2007;39(9):1083-91. doi: 10.1038/ng2103 pmid: 17660817
9. Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M,
et al. Oncogenic IL7R gain-of-function mutations in childhood
T-cell acute lymphoblastic leukemia. Nat Genet.
2011;43(10):932-9. doi: 10.1038/ng.924 pmid: 21892159
10. Hoe E, McKay FC, Schibeci SD, Gandhi K, Heard RN, Stewart
GJ, et al. Functionally significant differences in expression of
disease-associated IL-7 receptor alpha haplotypes in CD4 T
cells and dendritic cells. J Immunol. 2010;184(5):2512-7. doi:
10.4049/jimmunol.0902900 pmid: 20097866
11. Bashinskaya VV, Kulakova OG, Boyko AN, Favorov AV,
Favorova OO. A review of genome-wide association studies for
multiple sclerosis: classical and hypothesis-driven approaches.
Hum Genet. 2015;134(11-12):1143-62. doi:
10.1007/s00439-015-1601-2 pmid: 26407970
12. Albert PR. What is a functional genetic polymorphism?
Defining classes of functionality. J Psychiatry Neurosci.
2011;36(6):363-5. doi: 10.1503/jpn.110137 pmid: 22011561
13. Simsek H, Geckin H, Sensoz NP, List EO, Arman A.
Association Between IL7R Promoter Polymorphisms and
Multiple Sclerosis in Turkish Population. J Mol Neurosci.
2019;67(1):38-47. doi: 10.1007/s12031-018-1205-0 pmid:
30443838
14. Haj MS, Nikravesh A, Kakhki MP, Rakhshi N. Association
study of four polymorphisms in the interleukin-7 receptor
alpha gene with multiple sclerosis in Eastern Iran. Iran J Basic
Med Sci. 2015;18(6):593.